2/11/2016 | BKCVIG | Fitch affirms Mylan on acquisition news
|
11/20/2015 | BKCVIG | Fitch applies BBB- IDR to Mylan
|
11/13/2015 | BKCVIG | Moody’s revises Mylan view to stable
|
9/24/2015 | BKCVIG | S&P rates Mylan loan BBB-
|
7/31/2015 | BKCVIG | Moody’s changes Mylan outlook to negative
|
7/28/2015 | BKCVIG | S&P revises Myland watch to negative
|
4/22/2015 | CVIG | Moody’s revises Mylan to developing
|
4/22/2015 | CVIG | S&P: Mylan on developing watch
|
4/9/2015 | CVIG | S&P puts Mylan on watch
|
3/12/2015 | CVIGLM | Mylan gets consents to amend filing requirements for nine note series
|
3/3/2015 | CVIGLM | Mylan seeks consents to amend filing requirements for notes
|
11/5/2014 | CV | Mylan’s $574 million notes convertible after reaching 130% hurdle
|
10/20/2014 | CV | Market Commentary: Convertibles market players watching for next trend; Ares Capital, American Realty better
|
10/3/2014 | CV | Market Commentary: Downsized Starwood edges up from discount; Salix flat to lower; Red Hat extends gains
|
10/2/2014 | CV | Market Commentary: Convertibles: ‘Bleeding has slowed’; new Red Hat expands unexpectedly; Starwood on tap
|
7/15/2014 | CVHYIG | S&P changes Mylan outlook to positive
|
7/14/2014 | CV | Market Commentary: Macquarie stretches to 107; Tesla flat to better on higher shares; Exelixis stock surges
|
7/14/2014 | CV | Market Commentary: Morning Commentary: Mylan in focus on M&A news; Macquarie in trade; GT Advanced shares slump
|
2/19/2014 | CV | Market Commentary: Tesla in focus, shares surge after hours; Chemed pulls back in line with stock; Genco down
|
11/19/2013 | BKCVIG | Moody's rates Mylan notes Baa3
|
11/19/2013 | CVHYIG | S&P assigns Mylan notes BBB-
|
1/28/2013 | CV | Market Commentary: AMD gains; Chiquita adds on debt financing; School Specialty, Powerwave file bankruptcy
|
12/12/2012 | BKCVIG | S&P rates Mylan notes BBB-
|
12/12/2012 | BKCVIG | Moody's rates Mylan notes Baa3, cuts loans to Baa3
|
11/20/2012 | BKCVHYIG | S&P upgrades Mylan debt, cuts loans
|
11/20/2012 | BKCVHYIG | Moody's ups Mylan from junk
|
5/23/2012 | BKCVHYIG | Moody's upgrades Mylan
|
4/27/2012 | CVLM | Mylan says holders may convert $575 million of convertibles due 2015
|
11/10/2011 | CV | Market Commentary: Take-Two's planned $200 million deal in focus ahead of pricing; Regeneron trades at 92.75
|
10/13/2011 | BKCVHYIG | S&P rates Mylan loan BBB
|
10/13/2011 | BKCVHYIG | Moody's rates Mylan loan Baa3
|
8/10/2011 | CV | Market Commentary: Convertibles 'heavy' amid equity sell-off; Brookdale collapses to mid-70s; Hertz lower
|
8/3/2011 | CV | Market Commentary: Convertibles find footing; high-grade names outperform junk; Mylan drops; Cemex weaker
|
7/27/2011 | CV | Mylan stock price triggers conversion option on $575 million notes
|
7/14/2011 | CV | Market Commentary: Forest City climbs on debut; Electronic Arts up in gray market; Western Refining rises
|
6/27/2011 | CV | Market Commentary: Mylan contracts slightly in 'better for sale' market; Illumina adds; Microsoft at 102
|
5/3/2011 | BKCVHY | Mylan CFO: Deleveraging strategy unaffected by share-repurchase plans
|
5/3/2011 | CV | Market Commentary: Mylan off outright, expands on hedge; Incyte premium comes in; Alaska Communications on tap
|
3/11/2011 | CVIG | Moody's ups Mylan
|
3/10/2011 | BKCVHYIG | S&P upgrades Mylan
|
1/5/2011 | CV | Mylan de-lists 1.25% senior convertible notes due 2012 from Nasdaq
|
11/9/2010 | BKCVHY | S&P rates Mylan notes BB-
|
11/9/2010 | BKCVHY | Moody's rates Mylan notes B1
|
8/30/2010 | CV | Market Commentary: Intel active, unchanged after acquisition news; SanDisk steady to weaker; Mylan trades
|
7/30/2010 | CVHY | S&P rates Mylan add-on BB-
|
7/29/2010 | CVHY | Moody's: Mylan unchanged
|
7/20/2010 | CV | Market Commentary: Apache plans $1.1 billion sale of convertible mandatories; MGIC 'comes in' dollar neutral
|
7/15/2010 | CV | Market Commentary: Transocean gains as oil well leak stopped; AMD up ahead of results; Mylan merger raises prices
|
7/15/2010 | CVHY | S&P affirms Mylan
|
7/15/2010 | CVHY | Moody's: Mylan unchanged
|
7/14/2010 | CV | Market Commentary: Intel jumps on strong earnings; Ford, Micron, Microsoft up on optimism; Mylan to buy rival
|
5/21/2010 | CVHY | S&P rates Mylan shelf
|
5/20/2010 | CVHYPF | Mylan files automatic shelf registration for preferreds, debt, stock
|
5/5/2010 | BKCVHY | Moody's ups Mylan loans, rates notes B1
|
5/4/2010 | BKCVHY | S&P assigns Mylan notes BB-
|
4/29/2010 | CV | Market Commentary: Synovus moves up on debut; BorgWarner, Interpublic Group add on earnings; Mylan steady
|
3/4/2010 | BKCVHY | Moody's boosts Mylan
|
9/23/2009 | BKCVHY | S&P lifts Mylan to BB
|
8/21/2009 | CV | Market Commentary: Freeport higher on upbeat outlook; Mylan, Hologic, Allergan mixed; Alcoa, Newell unchanged
|
7/31/2009 | CV | Market Commentary: Hologic gains ahead of results; buybacks lift PDL; Sybase eases; Mylan up on earnings
|
7/27/2009 | CV | Market Commentary: Ford careens higher; Webster boosted by PIPE investment; Mylan mostly firm as shares drop
|
5/18/2009 | CV | Moody's ups Mylan outlook to positive
|
5/1/2009 | CV | Market Commentary: GM, Ford lower amid sales data, sector woes; Textron extends gains following debut; Mylan off
|
4/30/2009 | CV | Market Commentary: New issues continue to pace outsized gains; Textron up on debut; ProLogis gains on earnings
|
2/25/2009 | CV | Market Commentary: Citi, Bank of America, Wells Fargo gain on assurances; GM up with market; Mylan rises on drug nod
|
2/24/2009 | CV | Market Commentary: Convertibles activity improves: financials gain, but AIG weak; JA Solar adds; Mylan stronger
|
1/21/2009 | CV | Market Commentary: Financial preferreds bounce a little from big drop; health care, biotech names in trade; Avnet edges higher
|
12/18/2008 | CV | Market Commentary: Convertibles stronger: Mylan adds 0.5 point; strong bid on IG names; Allergan 1.5% notes up to par
|
12/15/2008 | CV | Market Commentary: Convertibles mostly quiet; iStar Financial floaters little changed; Mylan weaker; Amgen strengthens
|
9/19/2008 | CV | Market Commentary: Ban on short selling takes wind out of convertibles; financials quiet, overall market slips dollar neutral
|
9/15/2008 | CV | Mylan greenshoe fully exercised, lifts 3.75% seven-year convertibles to $575 million
|
9/11/2008 | CV | Market Commentary: Financial rout broadens, but Bank of America holds up; Oscient Pharma weakens after exchange news
|
9/10/2008 | CV | New Issue: Mylan prices upsized $500 million seven-year convertibles to yield 3.75%, up 20%
|
9/10/2008 | CV | Market Commentary: Lehman, WaMu weaken further; Chesapeake bounces a little with shares; Tyson gains on debut
|
9/9/2008 | BKCVHY | Moody's affirms Mylan
|
9/9/2008 | CV | Mylan to price $400 million seven-year convertibles to yield 2.875%-3.375%, up 20%-25%
|
9/9/2008 | CV | Market Commentary: Lehman declines, other financials weaken; Mylan, NVR expected to price offerings after the close
|
9/9/2008 | BKCVHY | S&P assigns Mylan convertibles B+
|
9/8/2008 | CV | Mylan plans $400 million of seven-year convertibles
|
9/8/2008 | CV | Market Commentary: Fannie Mae, Sovereign, Lehman crash, Wachovia improves on Fannie-Freddie bailout; UAL ignores rumor
|
5/9/2008 | CV | Market Commentary: Cheniere Energy plunges; El Paso gains; Legg Mason slips; Fannie Mae, TTM flat on debut; AIG to price
|
3/5/2008 | CV | Market Commentary: Convertibles mostly lower, but new issues move up; Ambac preferreds to price
|
2/29/2008 | CV | Market Commentary: EMC, Mylan, Sprint, National Retail convertibles all lower; Teva flat; equities sink
|
2/28/2008 | CV | Market Commentary: Convertibles mostly lower; National Retail edges below par; Thornburg, Nextel drop
|
2/27/2008 | CV | Market Commentary: Convertibles trade mixed; Teva, Fannie Mae active; National Retail prices upsized notes
|
2/7/2008 | CV | Market Commentary: UAL, Continental up on merger talk; Chiquita comes in big and rich; Bunge down on guidance
|
1/11/2008 | CV | Market Commentary: Countrywide active on BofA buyout; WaMu up on rumored deal; Sciele, Mylan up in search for safety
|
12/3/2007 | CV | Market Commentary: Countrywide slips as mortgage deal nears; Microchip Technology, Hologic, Transocean announce big deals
|
11/19/2007 | CV | Mylan greenshoe exercised, raising convertibles to $2.14 billion
|
11/15/2007 | BKCVHY | Moody's cuts Mylan, rates loans B1
|
11/15/2007 | CV | Market Commentary: Avery Dennison opens higher; Freeport-McMoRan, Newmont give back gains; Countrywide, Fannie Mae plunge
|
11/14/2007 | BKCVHY | S&P cuts Mylan, rates loans BB, convertibles B-
|
11/14/2007 | CV | New Issue: Mylan prices upsized $1.86 billion mandatory convertible preferred stock with 6.5% dividend, up 22%
|
11/14/2007 | CV | Market Commentary: Affymetrix, Mylan rich and up; Freeport-McMoRan, Newmont up with metals; AMR mixed
|
11/1/2007 | CV | Mylan launches $1.4 billion mandatory convertible preferreds due 2010, talked to yield 6.5%-7%, up 18%-22%
|
11/1/2007 | CV | Market Commentary: Successful test spurs United Therapeutics; iStar, Countrywide down with financials; tough day for four new issues
|